Evidence map›Paper›PMID 25544260›Full record

SynthesisMedical science monitor : international medical journal of experimental and clinical research2014

Methylenetetrahydrofolate reductase 677TT genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.

Nan-Bo Liu, Jun Li, Jia-Feng Qi, Zhen-Zhong Zhang, Xu Wu, Jun-Hua Zhang

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Medical science monitor : international medical journal of experimental and clinical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Associations Between Gestational Diabetes Mellitus Risk and Folate Status in Early Pregnancy andDiabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nan-Bo LiuDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China (mainland).
Jun LiDepartment of Thoracic Surgery, Third Affiliated Hospital, Southern Medical University, Guangzhou, China (mainland).
Jia-Feng QiDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China (mainland).
Zhen-Zhong ZhangDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China (mainland).
Xu WuDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China (mainland).
Jun-Hua ZhangDepartment of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China (mainland).
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough many epidemiology studies have investigated the methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and their associations with lung cancer (LC), definite conclusions cannot be drawn. To clarify the effects of MTHFR polymorphisms on the risk of LC, we performed a meta-analysis in Chinese populations. MATERIAL/

methodsRelated studies were identified from PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biology Medicine (CBM) until 16 February 2014. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the associations.

resultsA total of 11 studies with 2487 LC cases and 3228 controls were included in this meta-analysis. Overall, no significant association was found between MTHFR C677T polymorphism and LC risk when all studies in Chinese populations were pooled into this meta-analysis. In subgroup analyses stratified by geographical location and source of controls, significantly increased risk was found in North China (T vs. C: OR=1.28, 95% CI: 1.14-1.44; TT vs. CC: OR=1.67, 95% CI: 1.33-2.10; TT + CT vs. CC, OR=1.39, 95% CI=1.15-1.69; TT vs. CC + CT: OR=1.46, 95% CI: 1.03-2.06) and in population-based studies (TT vs. CC: OR=1.37, 95% CI: 1.14-1.65; TT vs. CC + CT: OR=1.25, 95% CI: 1.07-1.45).

conclusionsThis meta-analysis provides evidence that MTHFR C677T polymorphism may contribute to LC development in North China. Studies with larger sample sizes and wider spectrum of populations are warranted to verify this finding.

Indexed as

Genetic Predisposition to DiseaseChinaConfidence IntervalsHumansLung NeoplasmsMethylenetetrahydrofolate Reductase (NADPH2)Odds RatioPolymorphism, Single NucleotidePublication BiasRisk FactorsMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Identifiers

PMID25544260
PMCPMC4285940
OpenAlexW2168557068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.